Epicore BioNetworks Inc. Reports Personnel Changes and Stock Option Grants
CALGARY, Nov. 20, 2012 /PRNewswire/ – The Board of Directors of Epicore
BioNetworks Inc. is pleased to announce that Mr. Russell Rosenzweig has
accepted the position of Epicore Chief Financial Officer and Company
Secretary. Mr. Rosenzweig has been Epicore Networks (U.S.A.), Inc.
Controller since May 2012. Mr. Rosenzweig joins the Company in a
period of strong sales growth and at the beginning of a new phase in
corporate manufacturing capability. Mr. Rosenzweig’s varied financial
experience is expected to contribute significantly as the Company looks
to expand its core aquaculture business and to explore new business
Mr. Rosenzweig replaces Mr. Keith Blackman as CFO. Mr. Blackman, who
also is the President of Karver Consulting Services, has relocated his
business to Florida. He has been Epicore’s CFO since September 2007.
The Board wishes him well.
Epicore BioNetworks Inc. announces that it has granted stock options to
officers and employees of the company. The number of options granted
to officers is 400,000 and to employees also is 400,000. The total
800,000 granted is equivalent to 3.3% of Epicore’s issued common stock.
Under the terms of the Epicore Stock Option Plan, options may be issued
from time to time in any amount up to a maximum of 4,704,246 Epicore
common shares. These options have an exercise price of Cdn $0.215 and
expire in five years.
Epicore BioNetworks Inc. is a leading producer of environmental
biotechnology and animal nutrition products. It manufactures in the
USA and markets worldwide to a variety of industries to reduce
environmental pollution and increase operational productivity. Epicore
is a major supplier to the shrimp aquaculture industry.
Epicore BioNetworks Inc. is a public corporation with a registered
office in Calgary, Alberta, Canada and with shares listed on the TSX
Venture Exchange (symbol EBN). [Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the policies
of the TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.]
This press release contains forward-looking statements that involve
significant risks and uncertainties. The actual results, performance
or achievements of the company might differ materially from the
results, performance or achievements of the company expressed or
implied by such forward-looking statements. Such forward-looking
statements include, without limitation, those regarding the future
growth of the Company, the development plans of the company, and the
expected timing and results of such development. We can provide no
assurance that such development will proceed as currently anticipated,
that the expected timing or results of such development will be
realized or that the company will be able to generate sufficient cash
to meet its obligations. We are subject to various risks, including
the uncertainties of product development, markets for our products and
regulatory review, our need for additional capital to fund our
operations, our reliance on collaborative partners, our history of
losses, and other risks inherent in the biotechnology industry.
SOURCE Epicore BioNetworks Inc.